WMS Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-5,150
Closed -$461K 228
2018
Q3
$461K Sell
5,150
-219
-4% -$19.4K 0.05% 128
2018
Q2
$426K Buy
5,369
+251
+5% +$20.8K 0.05% 137
2018
Q1
$457K Sell
5,118
-4,451
-47% -$427K 0.05% 125
2017
Q4
$999K Buy
9,569
+344
+4% +$38.8K 0.11% 79
2017
Q3
$1.34M Buy
9,225
+419
+5% +$57.1K 0.16% 72
2017
Q2
$1.14M Sell
8,806
-450
-5% -$55.1K 0.14% 73
2017
Q1
$1.15M Sell
9,256
-168
-2% -$20.1K 0.14% 72
2016
Q4
$1.09M Sell
9,424
-277
-3% -$30.8K 0.14% 73
2016
Q3
$1.01M Sell
9,701
-3,482
-26% -$377K 0.14% 74
2016
Q2
$1.3M Buy
13,183
+4,414
+50% +$457K 0.18% 71
2016
Q1
$878K Buy
8,769
+100
+1% +$10.3K 0.12% 82
2015
Q4
$1.04M Buy
8,669
+1,500
+21% +$174K 0.15% 76
2015
Q3
$775K Sell
7,169
-20,142
-74% -$2.5M 0.12% 89
2015
Q2
$3.16M Sell
27,311
-707
-3% -$80.8K 0.37% 59
2015
Q1
$3.23M Buy
28,018
+21,065
+303% +$2.52M 0.4% 56
2014
Q4
$778K Sell
6,953
-12,138
-64% -$1.28M 0.12% 88
2014
Q3
$1.81M Buy
19,091
+1,133
+6% +$102K 0.28% 61
2014
Q2
$1.54M Buy
17,958
+1,930
+12% +$147K 0.24% 67
2014
Q1
$1.12M Buy
16,028
+2,128
+15% +$169K 0.18% 80
2013
Q4
$1.18M Hold
13,900
0.19% 74
2013
Q3
$1.07M Hold
13,900
0.2% 70
2013
Q2
$813K Buy
+13,900
New +$836K 0.15% 88

Other funds holding CELG

WMS Partners's CELG Position: Q4 2018 in Review

WMS Partners sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 5,150 shares — an estimated $461K sold.

WMS Partners first reported a position in CELG in Q2 2013 and held it in 22 quarters. The position peaked at $3.23M in Q1 2015. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • WMS Partners reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • WMS Partners sold 5,150 Celgene Corp shares in Q4 2018, an estimated $461K.
  • WMS Partners first reported a position in Celgene Corp in Q2 2013 and held it in 22 quarters.
  • WMS Partners's Celgene Corp position peaked at $3.23M in Q1 2015.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on WMS Partners's 13F filing for Q4 2018, filed 14 Feb 2019.